Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,376.00
(
0.55%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.25
(
-0.21%
)
Bitcoin
71,919.98
(
0.18%
)
News Focus
News Focus
Post# of 57683
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

haysaw

Send PM Follow Ignore
Followers 14
Posts 2972
Boards Moderated 0
Alias Born 07/19/2006

haysaw

Re: neuroinv post# 30742

Saturday, 11/14/2009 4:29:26 PM

Saturday, November 14, 2009 4:29:26 PM

Post# of 57683
<<The 'entire purpose' is not their concern>>

Okay, so they have no issue with dosing CX-717 in human AD subjects. That is what I thought. Sounds like a green light to me.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today